ArticleInternational journal of surgery (London, England)2026
Effectiveness of platelet-rich plasma plus microfracture compared with microfracture alone in the treatment of knee cartilage lesions: a systematic review and meta-analysis of comparative studies.
Article in International journal of surgery (London, England), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed, 1 synthesis or guideline pooled it.
- Comparative efficacy of platelet-rich plasma monotherapy versus combination therapies for knee osteoarthritis: a systematic review and network meta-analysis.Journal of orthopaedic surgery and research · 2026Pooled it
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundPlatelet-rich plasma (PRP) combined with microfracture (MF) has shown promising potential in the treatment of knee cartilage lesions. Therefore, the purpose of this study was to perform a meta-analysis to critically evaluate and compare the efficacy of using PRP + MF versus MF alone for the treatment of knee cartilage lesions in terms of short- and medium-term clinical outcomes.
methodWe systematically searched the PubMed, Cochrane Library, Embase, Google Scholar, and Web of Science databases for all relevant articles published from inception to July 2025. Clinical outcomes included Visual Analog Scale (VAS), International Knee Documentation Committee (IKDC), Tegner Score, Lysholm Score, and Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC). An effect size with a P -value less than 0.05 was considered statistically significant. Statistical analysis was performed using the meta package in R (version 4.3.3).
resultsA total of 11 studies, comprising 6 randomized controlled trials (RCTs) and 5 cohort studies, were included, totaling 664 patients. The main finding of this study is that the PRP + MF group demonstrated significantly improved VAS scores at the 3-, 12-, and 24-month follow-up; IKDC scores at the 24-month follow-up; Lysholm scores at the 3-, 6-, 12-, and 24-month follow-up; and Tegner scores at the 3-month follow-up compared to the MF group. However, there were no statistically significant differences between the two groups in the WOMAC score . Subgroup analyses showed superior Lysholm scores at 3 and 12 months and an IKDC score at 24 months in RCTs for the PRP + MF group compared to MF alone, while no significant differences were observed in VAS, Tegner, and WOMAC scores. In cohort studies, the PRP + MF group was associated with improved VAS at 3, 6, and 12 months; IKDC at 6 and 24 months, and Lysholm scores at 3 and 6 months, whereas Tegner scores showed no significant difference.
conclusionCompared with MF alone, PRP + MF produced clinically meaningful improvement in functional outcomes and pain control. The results of the present study may provide preliminary evidence for selecting treatments for knee cartilage lesions. However, higher-quality clinical studies with more quantitative outcomes are needed to confirm these results and determine the long-term effectiveness and safety of PRP augmentation following MF.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.